News

This will be the first phase III study to investigate whether adjuvant treatment with Tykerb will improve disease-free survival in women with early-stage HER2 breast cancer, including those

The company believes Oxytrex offers less physical dependence and withdrawal than oxycodone, the prescription painkiller widely used to treat persistent severe chronic pain. This study is evaluating patients

Provision of the additional information will allow the FDA to determine the comparability of the new data to that contained within the original Trexima new drug application and

The phase I study will be conducted using single and multiple oral doses with the objective of assessing safety and bioavailability of GRC 6211 in healthy human beings.

Before entering into this agreement Lonza and Solvay already had an ongoing commercial partnership. As part of the manufacturing alliance Lonza will produce an important selection of Solvay's

“Chronic hepatitis C infection is a major public health problem, and Vertex's goal is to increase the success rate of hepatitis C treatment with short-duration therapy,” said Joshua

The letter covers all formulations or drug combinations of phenylbutyrate being developed for the treatment of recurrent brain tumors. In addition to current worldwide rights, Somanta obtains a

PR-15 is being evaluated in a phase I single dose study which aims to define the safety, tolerability and PK/PD profile of the drug candidate. PR-15 is being

The Federal Trade Commission said it would not oppose the deal as long as the companies sell the drugs Zantac, Cortizone, Unisom and Balmex. Johnson & Johnson has